Literature DB >> 15916963

Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.

Erik Meulmeester1, Madelon M Maurice, Chris Boutell, Amina F A S Teunisse, Huib Ovaa, Tsion E Abraham, Roeland W Dirks, Aart G Jochemsen.   

Abstract

The p53 tumor suppressor protein has a major role in protecting the integrity of the genome. In unstressed cells, p53 is maintained at low levels by the ubiquitin-proteasome pathway. A balance between ubiquitin ligase activity (Hdm2, COP1, and Pirh2) and the ubiquitin protease activity of the Herpes virus-associated ubiquitin-specific protease (HAUSP) determines the half-life of p53. HAUSP also modulates p53 stability indirectly by deubiquitination and stabilization of Hdm2. The Hdmx protein affects p53 stability as well through its interaction with and regulation of Hdm2. Vice versa, Hdmx is a target for Hdm2-mediated ubiquitination and degradation. Here, we show that HAUSP also interacts with Hdmx, resulting in its direct deubiquitination and stabilization. HAUSP activity is required to maintain normal Hdmx protein levels. Therefore, the balance between HAUSP and Hdm2 activity determines Hdmx protein stability. Importantly, impaired deubiquitination of Hdmx/Hdm2 by HAUSP contributes to the DNA damage-induced degradation of Hdmx and transient instability of Hdm2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916963     DOI: 10.1016/j.molcel.2005.04.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  130 in total

Review 1.  Emerging role of Lys-63 ubiquitination in protein kinase and phosphatase activation and cancer development.

Authors:  W-L Yang; X Zhang; H-K Lin
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

2.  Regulation of p53 stability and function by the deubiquitinating enzyme USP42.

Authors:  Andreas K Hock; Arnaud M Vigneron; Stephanie Carter; Robert L Ludwig; Karen H Vousden
Journal:  EMBO J       Date:  2011-11-15       Impact factor: 11.598

3.  Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53.

Authors:  Lan Wang; Guifen He; Pingzhao Zhang; Xiang Wang; Mei Jiang; Long Yu
Journal:  Mol Biol Rep       Date:  2010-03-24       Impact factor: 2.316

4.  Regulation of vaccinia virus E3 protein by small ubiquitin-like modifier proteins.

Authors:  José González-Santamaría; Michela Campagna; María Angel García; Laura Marcos-Villar; Dolores González; Pedro Gallego; Fernando Lopitz-Otsoa; Susana Guerra; Manuel S Rodríguez; Mariano Esteban; Carmen Rivas
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  A stapled p53 helix overcomes HDMX-mediated suppression of p53.

Authors:  Federico Bernal; Mark Wade; Marina Godes; Tina N Davis; David G Whitehead; Andrew L Kung; Geoffrey M Wahl; Loren D Walensky
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

6.  Differential roles of ATM- and Chk2-mediated phosphorylations of Hdmx in response to DNA damage.

Authors:  Yaron Pereg; Suzanne Lam; Amina Teunisse; Sharon Biton; Erik Meulmeester; Leonid Mittelman; Giacomo Buscemi; Koji Okamoto; Yoichi Taya; Yosef Shiloh; Aart G Jochemsen
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 7.  The p53 orchestra: Mdm2 and Mdmx set the tone.

Authors:  Mark Wade; Yunyuan V Wang; Geoffrey M Wahl
Journal:  Trends Cell Biol       Date:  2010-02-19       Impact factor: 20.808

8.  SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

Authors:  Ping Yi; Weiya Xia; Ray-Chang Wu; David M Lonard; Mien-Chie Hung; Bert W O'Malley
Journal:  Genes Dev       Date:  2013-02-01       Impact factor: 11.361

Review 9.  Nucleotide Excision Repair: Finely Tuned Molecular Orchestra of Early Pre-incision Events.

Authors:  Qianzheng Zhu; Altaf A Wani
Journal:  Photochem Photobiol       Date:  2016-11-17       Impact factor: 3.421

Review 10.  Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?

Authors:  Mark Wade; Geoffrey M Wahl
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.